Clinical evaluation of the long-acting injectable neuroleptic, fluspirilene, in the treatment of schizophrenic and mentally retarded patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000627:therapeutic use; D007273:Injections, Intramuscular; D008607:Intellectual Disability / Q000188:drug therapy*; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D013141:Spiro Compounds / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D006846:Hydrocarbons, Halogenated; D010880:Piperidines; D013141:Spiro Compounds; D014149:Tranquilizing Agents